Prevalence and Determinants of Drug-Resistant Tuberculosis (DR-TB) Among Tuberculosis Patients in Pokhara Metropolitan City, Gandaki Province, Nepal.

Q3 Immunology and Microbiology
Interdisciplinary Perspectives on Infectious Diseases Pub Date : 2025-07-07 eCollection Date: 2025-01-01 DOI:10.1155/ipid/3730719
Shiv Kumar Sah, Chetan Karki Pyakurel, Arun Kathariya, Anil Shrestha, Nirmal Kumar Subedi, Niru Byanjankar, Rojina Basnet
{"title":"Prevalence and Determinants of Drug-Resistant Tuberculosis (DR-TB) Among Tuberculosis Patients in Pokhara Metropolitan City, Gandaki Province, Nepal.","authors":"Shiv Kumar Sah, Chetan Karki Pyakurel, Arun Kathariya, Anil Shrestha, Nirmal Kumar Subedi, Niru Byanjankar, Rojina Basnet","doi":"10.1155/ipid/3730719","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Drug-resistant tuberculosis (DR-TB) remains a significant global public health challenge, particularly in regions with a high burden of TB. Nepal, one such country, has been witnessing a rise in DR-TB cases, posing serious challenges to TB control efforts. Despite this growing concern, there is a lack of localized data on the risk factors contributing to DR-TB, especially in urban areas like Pokhara. This study aims to fill that gap by assessing the prevalence of DR-TB and identifying associated demographic, behavioral, and clinical factors among TB patients in Pokhara Metropolitan City, Gandaki Province, Nepal. <b>Methods:</b> A retrospective cross-sectional analysis was conducted using 617 TB patient records from the Pokhara Metropolitan Health Office for the fiscal year 2078/79 (July 2021 to July 2022). Data on demographic characteristics, clinical history, treatment regimens, and behavioral factors such as smoking and alcohol consumption were extracted. Descriptive statistics were used to determine the prevalence of DR-TB, and bivariate logistic regression was applied to identify statistically significant risk factors associated with DR-TB. <b>Results:</b> Among the 617 TB patients, the prevalence of DR-TB was 2.6%. Most patients were male (57.4%) and within the 21-30 age group (26.9%). Pulmonary bacteriologically confirmed TB was the most common type (53.6%), predominantly affecting adults (98.1%). The primary treatment regimen administered was 2HRZE + 4HR (78.8%). TB-HIV co-infection was found in 1.9% of cases, with all co-infected patients receiving antiretroviral therapy. In a bivariate analysis, individuals with current smoking status (UOR: 9.384; CI: 3.342-26.351), exposure to smoking (UOR: 8.550: CI: 2.916-25.064), and current alcohol consumption (UOR: 4.553, CI: 1.406-14.745) had a higher likelihood of DR-TB. In a multivariate analysis, exposure to smoking (AOR: 5.317; CI: 1.394-20.274) and current alcohol consumption (AOR: 6.84; CI: 2.071-22.58) emerged as independent predictors associated with an increased risk of DR-TB. <b>Conclusion:</b> The study revealed a relatively low prevalence of DR-TB among TB patients in Pokhara, with strong associations between DR-TB and lifestyle factors such as smoking and alcohol use. These findings underscore the need for targeted public health interventions addressing behavioral risk factors to reduce DR-TB incidence. Enhanced surveillance, public awareness, and preventive strategies should be integrated into TB control programs to mitigate the spread of DR-TB in this region. Moreover, targeted behavioral interventions may be crucial in curbing the emergence of DR-TB, particularly in high-burden urban centers.</p>","PeriodicalId":39128,"journal":{"name":"Interdisciplinary Perspectives on Infectious Diseases","volume":"2025 ","pages":"3730719"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12259324/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interdisciplinary Perspectives on Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/ipid/3730719","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Drug-resistant tuberculosis (DR-TB) remains a significant global public health challenge, particularly in regions with a high burden of TB. Nepal, one such country, has been witnessing a rise in DR-TB cases, posing serious challenges to TB control efforts. Despite this growing concern, there is a lack of localized data on the risk factors contributing to DR-TB, especially in urban areas like Pokhara. This study aims to fill that gap by assessing the prevalence of DR-TB and identifying associated demographic, behavioral, and clinical factors among TB patients in Pokhara Metropolitan City, Gandaki Province, Nepal. Methods: A retrospective cross-sectional analysis was conducted using 617 TB patient records from the Pokhara Metropolitan Health Office for the fiscal year 2078/79 (July 2021 to July 2022). Data on demographic characteristics, clinical history, treatment regimens, and behavioral factors such as smoking and alcohol consumption were extracted. Descriptive statistics were used to determine the prevalence of DR-TB, and bivariate logistic regression was applied to identify statistically significant risk factors associated with DR-TB. Results: Among the 617 TB patients, the prevalence of DR-TB was 2.6%. Most patients were male (57.4%) and within the 21-30 age group (26.9%). Pulmonary bacteriologically confirmed TB was the most common type (53.6%), predominantly affecting adults (98.1%). The primary treatment regimen administered was 2HRZE + 4HR (78.8%). TB-HIV co-infection was found in 1.9% of cases, with all co-infected patients receiving antiretroviral therapy. In a bivariate analysis, individuals with current smoking status (UOR: 9.384; CI: 3.342-26.351), exposure to smoking (UOR: 8.550: CI: 2.916-25.064), and current alcohol consumption (UOR: 4.553, CI: 1.406-14.745) had a higher likelihood of DR-TB. In a multivariate analysis, exposure to smoking (AOR: 5.317; CI: 1.394-20.274) and current alcohol consumption (AOR: 6.84; CI: 2.071-22.58) emerged as independent predictors associated with an increased risk of DR-TB. Conclusion: The study revealed a relatively low prevalence of DR-TB among TB patients in Pokhara, with strong associations between DR-TB and lifestyle factors such as smoking and alcohol use. These findings underscore the need for targeted public health interventions addressing behavioral risk factors to reduce DR-TB incidence. Enhanced surveillance, public awareness, and preventive strategies should be integrated into TB control programs to mitigate the spread of DR-TB in this region. Moreover, targeted behavioral interventions may be crucial in curbing the emergence of DR-TB, particularly in high-burden urban centers.

Abstract Image

尼泊尔甘达基省博卡拉市结核病患者中耐药结核病(DR-TB)的患病率和决定因素
背景:耐药结核病(DR-TB)仍然是一个重大的全球公共卫生挑战,特别是在结核病高负担地区。尼泊尔就是这样一个国家,耐药结核病病例一直在增加,对结核病控制工作构成严重挑战。尽管这一担忧日益加剧,但缺乏导致耐药结核病风险因素的本地化数据,特别是在博卡拉等城市地区。本研究旨在通过评估尼泊尔甘达基省博卡拉市结核病患者中耐药结核病的流行情况并确定相关的人口统计学、行为和临床因素来填补这一空白。方法:对2078/79财政年度(2021年7月至2022年7月)博卡拉市卫生局617例结核病病例进行回顾性横断面分析。提取了人口统计学特征、临床病史、治疗方案和行为因素(如吸烟和饮酒)的数据。描述性统计用于确定耐药结核病的流行情况,双变量逻辑回归用于确定与耐药结核病相关的具有统计学意义的危险因素。结果:617例结核患者中,耐药结核患病率为2.6%。大多数患者为男性(57.4%),年龄在21-30岁之间(26.9%)。肺部细菌学证实的结核病是最常见的类型(53.6%),主要影响成人(98.1%)。主要治疗方案为2HRZE + 4HR(78.8%)。在1.9%的病例中发现结核-艾滋病毒合并感染,所有合并感染的患者都接受抗逆转录病毒治疗。在双变量分析中,当前吸烟状态的个体(UOR: 9.384;CI: 3.342-26.351)、吸烟暴露(UOR: 8.550: CI: 2.916-25.064)和当前饮酒(UOR: 4.553, CI: 1.406-14.745)患耐药结核病的可能性更高。在多变量分析中,吸烟暴露(AOR: 5.317;CI: 1.394-20.274)和当前饮酒量(AOR: 6.84;CI: 2.071-22.58)成为与耐药结核病风险增加相关的独立预测因子。结论:该研究表明,博卡拉结核病患者中耐药结核病的患病率相对较低,耐药结核病与吸烟和饮酒等生活方式因素之间存在很强的相关性。这些发现强调需要针对行为风险因素采取有针对性的公共卫生干预措施,以减少耐药结核病的发病率。应将加强监测、提高公众意识和预防战略纳入结核病控制规划,以减轻耐药结核病在该地区的传播。此外,有针对性的行为干预可能对遏制耐药结核病的出现至关重要,特别是在高负担的城市中心。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
51
审稿时长
18 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信